Randi Y. Leavitt

26.5k total citations · 12 hit papers
71 papers, 16.7k citations indexed

About

Randi Y. Leavitt is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Randi Y. Leavitt has authored 71 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 27 papers in Infectious Diseases and 25 papers in Virology. Recurrent topics in Randi Y. Leavitt's work include Vasculitis and related conditions (28 papers), HIV/AIDS drug development and treatment (25 papers) and HIV Research and Treatment (25 papers). Randi Y. Leavitt is often cited by papers focused on Vasculitis and related conditions (28 papers), HIV/AIDS drug development and treatment (25 papers) and HIV Research and Treatment (25 papers). Randi Y. Leavitt collaborates with scholars based in United States, Switzerland and Germany. Randi Y. Leavitt's co-authors include Anthony S. Fauci, Gary S. Hoffman, Joseph L. Mills, D. Blöch, Stanley L. Wallace, Mary Betty Stevens, Dennis J. McShane, William P. Arend, Leonard H. Calabrese and Alfonse T. Masi and has published in prestigious journals such as New England Journal of Medicine, Cell and The Lancet.

In The Last Decade

Randi Y. Leavitt

70 papers receiving 16.0k citations

Hit Papers

Wegener Granulomatosis: An Analysis of 158 Patients 1974 2026 1991 2008 1992 1990 1990 1990 1990 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Wegener Granulomatosis: An Analysis of 158 Patients
    1992 2.0k citations Gary S. Hoffman, Gail S. Kerr et al. Annals of Internal Medicine profile →
  2. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
    1990 1.7k citations Gene G. Hunder, D. Blöch et al. Arthritis & Rheumatism profile →
  3. The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis
    1990 1.5k citations William P. Arend, Beat A. Michel et al. Arthritis & Rheumatism profile →
  4. The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)
    1990 1.5k citations Alfonse T. Masi, Gene G. Hunder et al. Arthritis & Rheumatism profile →
  5. The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis
    1990 1.4k citations Randi Y. Leavitt, Anthony S. Fauci et al. Arthritis & Rheumatism profile →
  6. Takayasu Arteritis
    1994 1.1k citations Gail S. Kerr, Claire W. Hallahan et al. Annals of Internal Medicine profile →
  7. Retrograde axonal transport and the demonstration of non‐specific projections to the cerebral cortex and striatum from thalamic intralaminar nuclei in the rat, cat and monkey
    1974 740 citations Randi Y. Leavitt et al. profile →
  8. The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa
    1990 732 citations Robert W. Lightfoot, Beat A. Michel et al. Arthritis & Rheumatism profile →
  9. The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpura
    1990 568 citations Joseph L. Mills, Beat A. Michel et al. Arthritis & Rheumatism profile →
  10. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
    2009 478 citations Jeffrey L. Lennox, Edwin DeJesus et al. The Lancet profile →
  11. The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction
    1990 435 citations Gene G. Hunder, William P. Arend et al. Arthritis & Rheumatism profile →
  12. The American College of Rheumatology 1990 criteria for the classification of vasculitis: Summary
    1990 417 citations James F. Fries, Gene G. Hunder et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randi Y. Leavitt United States 40 11.9k 6.2k 3.8k 2.1k 2.0k 71 16.7k
Allan Wiik Denmark 38 5.9k 0.5× 4.3k 0.7× 2.3k 0.6× 1.2k 0.6× 1.3k 0.6× 172 9.9k
Niels Rasmussen Denmark 38 7.2k 0.6× 2.8k 0.4× 2.9k 0.8× 1.7k 0.8× 932 0.5× 104 8.6k
Haralampos Μ. Moutsopoulos Greece 79 1.6k 0.1× 7.5k 1.2× 9.6k 2.6× 714 0.3× 2.4k 1.2× 402 21.5k
Robert Winchester United States 68 1.3k 0.1× 15.3k 2.5× 1.1k 0.3× 1.4k 0.7× 3.3k 1.7× 209 28.3k
R.K. Winkelmann United States 58 1.5k 0.1× 3.4k 0.5× 2.2k 0.6× 242 0.1× 1.8k 0.9× 389 14.1k
Keith B. Elkon United States 70 1.4k 0.1× 5.0k 0.8× 1.3k 0.3× 473 0.2× 4.7k 2.4× 203 16.4k
Robert B. Nussenblatt United States 76 2.1k 0.2× 5.1k 0.8× 1.3k 0.3× 212 0.1× 2.8k 1.4× 435 25.1k
Javier Martı́n Spain 60 2.0k 0.2× 5.8k 0.9× 686 0.2× 441 0.2× 3.3k 1.7× 499 15.0k
James T. Rosenbaum United States 66 2.2k 0.2× 5.2k 0.8× 1.9k 0.5× 191 0.1× 2.7k 1.3× 357 16.9k
Peter H. Schur United States 62 825 0.1× 6.6k 1.1× 736 0.2× 1.0k 0.5× 1.8k 0.9× 224 14.3k

Countries citing papers authored by Randi Y. Leavitt

Since Specialization
Citations

This map shows the geographic impact of Randi Y. Leavitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randi Y. Leavitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randi Y. Leavitt more than expected).

Fields of papers citing papers by Randi Y. Leavitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randi Y. Leavitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randi Y. Leavitt. The network helps show where Randi Y. Leavitt may publish in the future.

Co-authorship network of co-authors of Randi Y. Leavitt

This figure shows the co-authorship network connecting the top 25 collaborators of Randi Y. Leavitt. A scholar is included among the top collaborators of Randi Y. Leavitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randi Y. Leavitt. Randi Y. Leavitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prohn, Marita, Carolyn R. Cho, Anders Viberg, et al.. (2021). Exposure–Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients. Clinical Pharmacology & Therapeutics. 111(2). 485–495. 4 indexed citations
2.
Ofotokun, Ighovwerha, Raphael J. Landovitz, Heather J. Ribaudo, et al.. (2015). Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257. Clinical Infectious Diseases. 60(12). 1842–1851. 58 indexed citations
3.
Rockstroh, Jürgen K., Edwin DeJesus, Jeffrey L. Lennox, et al.. (2013). Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 63(1). 77–85. 167 indexed citations
4.
Nguyen, Bach‐Yen, Robin Isaacs, Hedy Teppler, et al.. (2011). Raltegravir: the first HIV‐1 integrase strand transfer inhibitor in the HIV armamentarium. Annals of the New York Academy of Sciences. 1222(1). 83–89. 41 indexed citations
5.
Rockstroh, Jürgen K., Jeffrey L. Lennox, Edwin DeJesus, et al.. (2011). Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1–Infected Patients: 156-Week Results From STARTMRK. Clinical Infectious Diseases. 53(8). 807–816. 139 indexed citations
6.
Lennox, Jeffrey L., Edwin DeJesus, Daniel S Berger, et al.. (2010). Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 39–48. 194 indexed citations
7.
Lennox, Jeffrey L., Edwin DeJesus, Adriano Lazzarin, et al.. (2009). Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. The Lancet. 374(9692). 796–806. 478 indexed citations breakdown →
8.
Harro, Clayton, Michael Robertson, Michelle Lally, et al.. (2008). Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults. AIDS Research and Human Retroviruses. 25(1). 103–114. 46 indexed citations
9.
Hirsch, Martin, Roy T. Steigbigel, S Staszewski, et al.. (2003). Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection. Clinical Infectious Diseases. 37(8). 1119–1124. 13 indexed citations
10.
Ognibene, Frederick P., James H. Shelhamer, Gary S. Hoffman, et al.. (1995). Pneumocystis carinii Pneumonia: A Major Complication of Immunosuppressive Therapy in Patients with Wegener's Granulomatosis. American Journal of Respiratory and Critical Care Medicine. 151(3_Part_1). 795–799. 136 indexed citations
11.
Hoffman, Gary S., Randi Y. Leavitt, Gail S. Kerr, et al.. (1994). Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate. Arthritis & Rheumatism. 37(4). 578–582. 245 indexed citations
12.
Kerr, Gail S., Claire W. Hallahan, Joseph Giordano, et al.. (1994). Takayasu Arteritis. Annals of Internal Medicine. 120(11). 919–929. 1130 indexed citations breakdown →
13.
Hoffman, Gary S., Gail S. Kerr, Randi Y. Leavitt, et al.. (1992). Wegener Granulomatosis: An Analysis of 158 Patients. Annals of Internal Medicine. 116(6). 488–498. 1958 indexed citations breakdown →
14.
Giordano, Joseph, Randi Y. Leavitt, Gary S. Hoffman, & A S Fauci. (1991). Experience with surgical treatment of Takayasu's disease.. PubMed. 109(3 Pt 1). 252–8. 68 indexed citations
15.
Leavitt, Randi Y., et al.. (1991). Wegenerʼs granulomatosis. Current Opinion in Rheumatology. 3(1). 8–14. 14 indexed citations
16.
Mills, Joseph L., Beat A. Michel, D. Blöch, et al.. (1990). The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpura. Arthritis & Rheumatism. 33(8). 1114–1121. 568 indexed citations breakdown →
17.
Masi, Alfonse T., Gene G. Hunder, J. T. Lie, et al.. (1990). The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis). Arthritis & Rheumatism. 33(8). 1094–1100. 1458 indexed citations breakdown →
18.
Hunder, Gene G., William P. Arend, D. Blöch, et al.. (1990). The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction. Arthritis & Rheumatism. 33(8). 1065–1067. 435 indexed citations breakdown →
19.
Blöch, D., Beat A. Michel, Gene G. Hunder, et al.. (1990). The American College of Rheumatology 1990 criteria for the classification of vasculitis: Patients and methods. Arthritis & Rheumatism. 33(8). 1068–1073. 174 indexed citations
20.
Holcombe, Randall F., William Strauss, Frances L. Owen, et al.. (1987). Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor γ chain in mouse and man. Genomics. 1(3). 287–291. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Allan Wiik Breakdown of academic impact, for papers by Niels Rasmussen Breakdown of academic impact, for papers by Haralampos Μ. Moutsopoulos Breakdown of academic impact, for papers by Robert Winchester Breakdown of academic impact, for papers by R.K. Winkelmann Breakdown of academic impact, for papers by Keith B. Elkon Breakdown of academic impact, for papers by Robert B. Nussenblatt Breakdown of academic impact, for papers by Javier Martı́n Breakdown of academic impact, for papers by James T. Rosenbaum Breakdown of academic impact, for papers by Peter H. Schur
Rankless by CCL
2026